A Single dose of methylphenidate beneficial to treat Attention Deficit Hyperactivity Disorder

July 20th 2013 (http://www.kamagrarx.co/) - A single dose of methylphenidate (MPH), used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy, helps to meliorate balance control during walking, and hence reduces the risk of falls among elderly adults. Falls in older adults are the prime cause of hip fractures and other injury-related visits to emergency rooms and of accidental death. Deterioration related to age in gait and balance is a major contributor to falls in older adults.

The researchers found that a single dose of MPH improves walking by reducing the number of step errors and the step error rate in both single and dual tasks. The research shows that MPH may have a role as a therapeutic option for improving gait and reducing fall risk in older adults. This is very true in real-life situations.

The study participants were 30 healthy older adults who were at least 70 years-old and had the ability to walk 70 feet (20 meters) without personal assistance or an assistive device. They were given a single dose (10 mg.) of MPH and were assessed under four task conditions of single and combined motor and cognitive tasks. The improve attention that comes about as a result of MPH may lead to improved balance control during walking, mainly in dual task conditions

The findings that MPH improves gait can be explained not just by its effect of attentional improvements, but also by indications that it has a direct influence on areas of the brain that deal with motor and balance control.

For more please visit : http://www.kamagrarx.co/

Kamagrarx 100 Railway Street, Sydney, NSW, 1211221111 AUSTRALIA-2766

Andy decosta completed his graduation in Biotechnology and also did PhD in Bio-pharmacology. He works as a medical consultant for kamagrarx.co